Peer-reviewedCC BYZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Eculizumab resistance caused by C5 gene polymorphism in a patient with paroxysmal nocturnal hemoglobinuria: a case report].
- 1Department of Hematology, Guangzhou First People's Hospital, Guangzhou 510180, China.
- 2Haisco Pharmaceutical Group Co., Ltd., Chengdu 611100, China.
Related
- FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye
- Abdominal Magnetic Resonance Imaging (MRI) Findings Prompting the Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: A Case Report.
- Iptacopan combined with immunosuppressive therapy for aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report.
- Eculizumab in rapidly progressive glomerulonephritis: a case-series report
- Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation
BibTeX
@article{zhou2026eculizumab,
title = {{[Eculizumab resistance caused by C5 gene polymorphism in a patient with paroxysmal nocturnal hemoglobinuria: a case report].}},
author = {R Q Zhou and W Zhou and Y L Xu and X W Chen and F Q Li and S Q Wang},
journal = {Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi},
year = {2026},
month = aug,
doi = {10.3760/cma.j.cn121090-20260421-00205},
url = {https://europepmc.org/article/MED/42851185},
note = {CC BY},
}
RIS
TY - JOUR
TI - [Eculizumab resistance caused by C5 gene polymorphism in a patient with paroxysmal nocturnal hemoglobinuria: a case report].
AU - R Q Zhou
AU - W Zhou
AU - Y L Xu
AU - X W Chen
AU - F Q Li
AU - S Q Wang
PY - 2026
DA - 2026/08/01
JO - Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
DO - 10.3760/cma.j.cn121090-20260421-00205
UR - https://europepmc.org/article/MED/42851185
SN - 0253-2727
SN - 2707-9740
ER -